SCHEMBL4975322

SCHEMBL4975322

NC(CNC(=O)O)CC1CCCCO1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.42
USP2 O75604 1/20 0.42
HPGD P15428 5/20 0.41
TP53 P04637 1/20 0.41
ALOX12 P18054 1/20 0.41
ANPEP P15144 1/20 0.40
HTT P42858 1/20 0.39
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
PKM P14618 1/20 0.37
CYP2C19 P33261 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.35
MCL1 Q07820 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3585503 1.00 SMN1; SMN2 (0.42) SMN1; SMN2USP2HPGDTP53ALOX12
SCHEMBL3585500 1.00 SMN1; SMN2 (0.42) SMN1; SMN2USP2HPGDTP53ALOX12
SCHEMBL27709407 0.95 SMN1; SMN2 (0.46) SMN1; SMN2USP2HPGDTP53ALOX12
SCHEMBL3590442 0.95 SMN1; SMN2 (0.46) SMN1; SMN2USP2HPGDTP53ALOX12
SCHEMBL3590446 0.95 SMN1; SMN2 (0.46) SMN1; SMN2USP2HPGDTP53ALOX12
SCHEMBL936034 0.76 GRIN2D (0.43) SMN1; SMN2USP2HPGDTP53ALOX12
SCHEMBL27689737 0.76 CYP2D6 (0.50) ANPEPCYP2D6
SCHEMBL3599048 0.76 CYP2D6 (0.50) ANPEPCYP2D6
SCHEMBL3599047 0.76 CYP2D6 (0.50) ANPEPCYP2D6
SCHEMBL3607476 0.75 ANPEP (0.37) SMN1; SMN2USP2HPGDTP53ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966139-A1 ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2008-09-10 EP disclosed
WO-2007070201-A1 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-06-21 WO disclosed